Focused Wealth Management, Inc - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2020$1,0000.0%2500.0%0.00%
Q1 2020$1,0000.0%2500.0%0.00%
Q4 2019$1,0000.0%2500.0%0.00%
Q3 2019$1,0000.0%2500.0%0.00%
Q2 2019$1,0000.0%2500.0%0.00%
Q1 2019$1,0002500.0%0.00%
Q4 2018$0
-100.0%
2500.0%0.00%
Q3 2018$1,0000.0%2500.0%0.00%
Q2 2018$1,0000.0%2500.0%0.00%
Q1 2018$1,0000.0%2500.0%0.00%
Q4 2017$1,0002500.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders